Because A549 cells have wild-type TP53 and both alleles of TP53 are eliminated in Calu-1 cells, they found that both 5-dAzaC and TSA could inhibit NSCLC cell proliferation in a p53-independent way. This evidence concerns the gene TP53 and non-small cell lung carcinoma.